Article: A short journey into Switzerland’s thriving pharmaceutical industry and innovation-friendly legislations

Article: A short journey into Switzerland’s thriving pharmaceutical industry and innovation-friendly legislations

Wednesday, 9 December, 2020

 

Switzerland’s economy and pharmaceutical industry are closely linked: pharma products made up 37.9% of all Swiss exports in 2018. The Swiss government does its best to encourage pharma innovation, introducing business-friendly legislation, low tax rates, tax deductions for R&D, and significantly reducing bureaucracy levels and the time needed to receive licenses for pharma products  (only 330 days).

Here you will find the full version of the article

 

 

1
2
3
4
1
2
3
4